期刊
NUTRIENTS
卷 14, 期 19, 页码 -出版社
MDPI
DOI: 10.3390/nu14193889
关键词
vitamin B3; nicotinamide riboside; health; COVID-19; dietary supplements
资金
- NIH/NIGMS [1R01GM143176-01A1]
- VCU CCTR Endowment Fund [UL1TR002649]
- National Center for Advancing Translational Sciences
Nicotinamide riboside (NR), as a potent NAD(+) enhancement agent, has shown promising results in protecting against various pathological conditions such as neurodegenerative diseases, diabetes, and hearing loss.
Among all the NAD(+) precursors, nicotinamide riboside (NR) has gained the most attention as a potent NAD(+)-enhancement agent. This recently discovered vitamin, B3, has demonstrated excellent safety and efficacy profiles and is orally bioavailable in humans. Boosting intracellular NAD(+) concentrations using NR has been shown to provide protective effects against a broad spectrum of pathological conditions, such as neurodegenerative diseases, diabetes, and hearing loss. In this review, an integrated overview of NR research will be presented. The role NR plays in the NAD(+) biosynthetic pathway will be introduced, followed by a discussion on the synthesis of NR using chemical and enzymatic approaches. NR's effects on regulating normal physiology and pathophysiology will also be presented, focusing on the studies published in the last five years.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据